NCT03356171

Brief Summary

APACCHE (Adapted Physical Activity and Cardiac Coherence in HEmatologic patients) study investigates effects of heart rate variability biofeedback training, combined with classical adapted physical activity, on health-related quality of life in patients previously treated for hematologic malignancies. It is a prospective, randomized clinical trial from University Hospital of Reunion Island. The main objective is evaluated with QLQ-C30 survey score differences.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 23, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 29, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2018

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 13, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 4, 2024

Completed
Last Updated

October 2, 2025

Status Verified

September 1, 2025

Enrollment Period

5.8 years

First QC Date

November 23, 2017

Last Update Submit

September 29, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Health-related quality of life

    Health-related quality is assessed by the Quality of Life Questionnaire dedicated to cancer patients and including 30 items (QLQ-C30) developed by the European Organization for Research and Treatment of Cancer (EORTC). This questionnaire is a multimodal construct, typically including physical, emotional and psychological health issues; evaluated with the QLQ-C30 survey of the European Organization for Research and Treatment of Cancer. QLQ-C30 items are coded with the same response categories as items 6 to 28, namely "Not at all", "A little", "Quite a bit" and "Very much." Score ranges from 0 to 100, with higher score indicating higher levels of quality of life.

    on week 12

Secondary Outcomes (3)

  • Fatigue improvement

    through study completion: initially (T1), at 6 weeks (T2), 12 weeks (T3) and after at 24 weeks (T4) follow-up

  • Anxiety and depression improvement with Hospital Anxiety and Depression Scale (HADS) survey

    through study completion: initially (T1), at 6 weeks (T2), 12 weeks (T3) and after at 24 weeks (T4) follow-up

  • Cardiac coherence improvement

    through study completion: initially (T1), at 6 weeks (T2), 12 weeks (T3) and after at 24 weeks (T4) follow-up

Study Arms (2)

Cardiac Coherence

EXPERIMENTAL

Patients participate to Adapted physical activity sessions and to cardiac coherence sessions

Procedure: Cardiac Coherence

Adapted Physical Activity

ACTIVE COMPARATOR

Patients only participate to Adapted physical activity sessions

Procedure: Adapted Physical Activity

Interventions

* 10 sessions of HRV-BF (45mn) weekly over 12 weeks. HRV-BF is a cognitive behavioural therapy consisting on stress management training based on breathing. We use the SYMBIOLINE PC software to record the heart rate variability biofeedback, with an infrared plethysmograph sensor. The sensor is put on the finger, and the patient's HRV pattern is displayed in real time. * 24 APA sessions (1.5h) bi-weekly over 12 weeks. Each session includes aerobic exercises (walk, step) and resistant exercises (muscular reinforcement). This program is built on previous cancer studies to make it effective.

Cardiac Coherence

\- 24 APA sessions (1.5h) bi-weekly over 12 weeks. Each session includes aerobic exercises (walk, step) and resistant exercises (muscular reinforcement). This program is built on previous cancer studies to make it effective.

Adapted Physical Activity

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients, previously treated and in remission for an Hematologic malignancy, in whom APA is indicated.
  • Adult patients aged 18-65 yo
  • Followed at South University Hospital of La Réunion Island
  • Previously treated for Hematologic Malignancy, and in Remission (complete or partial)
  • months or less since last treatment
  • Hemoglobin steady ≥ 90g/L
  • In whom APA is prescribed
  • Ability to give oral informed consent
  • French understanding

You may not qualify if:

  • With contraindication for APA
  • Under anti-arhythmic or beta-blocker drugs
  • Cardiac insufficiency (Left ventriculi Ejection Fraction less than 40%)
  • Participation in another trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Universitaire de La Réunion

Saint-Pierre, 97410, Reunion

Location

Related Publications (1)

  • Fournie C, Bouscaren N, Dalleau G, Lenclume V, Mohr C, Zunic P, Cabrera Q, Verkindt C. Adapted physical activity and cardiac coherence in hematologic patients (APACCHE): study protocol for a randomized controlled trial. BMC Sports Sci Med Rehabil. 2020 Mar 14;12:18. doi: 10.1186/s13102-020-00170-3. eCollection 2020.

MeSH Terms

Conditions

Motor ActivityNeoplasmsHematologic Diseases

Condition Hierarchy (Ancestors)

BehaviorHemic and Lymphatic Diseases

Study Officials

  • Quentin CABRERA, MD

    Centre Hospitalier Universitaire de La REUNION, France

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2017

First Posted

November 29, 2017

Study Start

January 1, 2018

Primary Completion

October 13, 2023

Study Completion

April 4, 2024

Last Updated

October 2, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations